KUCHING: The Ministry of Health (MoH) has allocated 2,400 doses of Pfizer’s oral antiviral drug Paxlovid for Sarawak.
Deputy Premier Datuk Seri Dr Sim Kui Hian revealed that 48,000 doses of the extremely high demand Paxlovid arrived in Malaysia on Saturday (April 9).
He had recently attended a follow-up meeting with Pfizer Malaysia on the antiviral drug.
“The Sarawak COVID-19 Advisory Group (SCOVAG) of local health experts and the state secretariat will follow up negotiations and legal paperwork for the state government to buy additional doses to complement MoH’s allocation for Sarawak.
“Similar to December last year following advices from SCOVAG, the state government had acquired Roche’s single-dose antibody cocktail Ronapreve (which costs around $5,000 per dose) for MoH hospitals in Sarawak,” he said yesterday (April 12).
The Minister of Public Health, Housing, Local Government noted that Premier Datuk Patinggi Tan Sri Abang Johari Tun Openg had issued a directive to acquire the latest scientific proven medications for Sarawakians.
“This is to supplement or complement the MoH if necessary, as the lives of Sarawakians must come first even though health is under the federal government,” he added.
Separately, Dr Sim said all hospitals would now begin taking in COVID-19 patients as part of living with the virus.
“All hospitals will take patients with COVID-19, it is no more just COVID-19 hospitals like Sarawak General Hospital, Sibu Hospital, Bintulu Hospital or Miri Hospital,” he said.